相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain
Catherine E. Creeley et al.
NEUROBIOLOGY OF AGING (2008)
Pathologically-activated therapeutics for neuroprotection: Mechanism of NMDA receptor block by memantine and S-nitrosylation
Stuart A. Lipton
CURRENT DRUG TARGETS (2007)
Natural oligomers of the Alzheimer amyloid-β protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway
Ganesh M. Shankar et al.
JOURNAL OF NEUROSCIENCE (2007)
Aβ oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease
Pascale N. Lacor et al.
JOURNAL OF NEUROSCIENCE (2007)
Spatial relationship between synapse loss and β-amyloid deposition in Tg2576 mice
Hongxin Dong et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
Preclinical investigation of the functional effects of memantine and memantine combined with galantamine or donepezil
Diana S. Woodruff-Pak et al.
NEUROPSYCHOPHARMACOLOGY (2007)
Anti-dementia drugs and hippocampal-dependent memory in rodents
Carla M. Yuede et al.
BEHAVIOURAL PHARMACOLOGY (2007)
Low doses of memantine disrupt memory in adult rats
C Creeley et al.
JOURNAL OF NEUROSCIENCE (2006)
Effect of subchronic treatment of memantine, galantamine, and nicotine in the brain of Tg2576 (APPswe) transgenic mice
C Unger et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2006)
Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond
SA Lipton
NATURE REVIEWS DRUG DISCOVERY (2006)
Cognitive evaluation of disease-modifying efficacy of galantamine and memantine in the APP23 model
D Van Dam et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2006)
Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine
Gary L. Wenk et al.
BEHAVIOURAL PHARMACOLOGY (2006)
Synaptic activity regulates interstitial fluid amyloid-β levels in vivo
JR Cirrito et al.
NEURON (2005)
Physicochemical characteristics of soluble oligomeric Aβ and their pathologic role in Alzheimer's disease
D Watson et al.
NEUROLOGICAL RESEARCH (2005)
Acetylcholinesterase inhibitors ameliorate behavioral deficits in the Tg2576 mouse model of Alzheimer's disease
HX Dong et al.
PSYCHOPHARMACOLOGY (2005)
Symptomatic effect of donepezil, rivastigmine, galantamine and memantine on cognitive deficits in the APP23 model
D Van Dam et al.
PSYCHOPHARMACOLOGY (2005)
Memantine blocks α7*nicotinic acetylcholine receptors more potently than N-methyl-D-aspartate receptors in rat hippocampal neurons
Y Aracava et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Impaired Pavlovian cued fear conditioning in Tg2576 mice expressing a human mutant amyloid precursor protein gene
P Barnes et al.
BEHAVIOURAL BRAIN RESEARCH (2005)
No nerve growth factor response to treatment with memantine in adult rats
UE Lang et al.
JOURNAL OF NEURAL TRANSMISSION (2004)
Multi-metric behavioral comparison of APPsw and P30IL models for Alzheimer's Disease: linkage of poorer cognitive performance to tau pathology in forebrain
GW Arendash et al.
BRAIN RESEARCH (2004)
Modulation of hippocampal cell proliferation, memory, and amyloid plaque deposition in APPsw (Tg2576) mutant mice by isolation stress
H Dong et al.
NEUROSCIENCE (2004)
Memantine improves spatial learning in a transgenic mouse model of Alzheimer's disease
R Minkeviciene et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Hippocampal neurons in pre-clinical Alzheimer's disease
MJ West et al.
NEUROBIOLOGY OF AGING (2004)
Cortical synaptic integration in vivo is disrupted by amyloid-β plaques
EA Stern et al.
JOURNAL OF NEUROSCIENCE (2004)
Alzheimer's disease-affected brain:: Presence of oligomeric Aβ ligands (ADDLs) suggests a molecular basis for reversible memory loss
YS Gong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence
W Danysz et al.
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY (2003)
Amyloid deposition in the hippocampus and entorhinal cortex: Quantitative analysis of a transgenic mouse model
JF Reilly et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
NMDA receptor blockade and hippocampal neuronal loss impair fear conditioning and position habit reversal in C57Bl/6 mice
ME Bardgett et al.
BRAIN RESEARCH BULLETIN (2003)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
C Lappe-Siefke et al.
NATURE GENETICS (2003)
Age-dependent cognitive decline in the APP23 model precedes amyloid deposition
D Van Dam et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Neuroprotection by memantine against neurodegeneration induced by β-amyloid(1-40)
JJ Miguel-Hidalgo et al.
BRAIN RESEARCH (2002)
Overexpression of hAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease
KA Corcoran et al.
LEARNING & MEMORY (2002)
Inhibitory synapse cover on the somata of excitatory neurons in macaque monkey visual cortex
JS Lund et al.
CEREBRAL CORTEX (2001)
Signal-processing machines at the postsynaptic density
MB Kennedy
SCIENCE (2000)
Differential effects of NMDA-receptor antagonists on long-term potentiation and hypoxic/hypoglycaemic excitotoxicity in hippocampal slices
T Frankiewicz et al.
NEUROPHARMACOLOGY (2000)
分享论文
